Sachio Pharma Bangalore Pvt. Ltd.
Winner of India 5000 Best MSME Awards 2023
Sachio Pharma Bangalore Pvt. Ltd.
Winner of India 5000 Best MSME Awards 2023
Details
Sachio Pharma Bangalore Pvt. Ltd.
Private Limited Company
Health Products, Drug and Medicine
Pharmaceuticals.
2013
104
Mumbai City
Mumbai - 400057
Maharashtra
Videos
Introduction
Sachio is spreading its wings across India to help the ailing masses through innovative products using Novel Technologies & 24x7 customer care initiatives.
Sachio has inked International collaborations Novocare Biosciences, Canada & Hanook Biosciences, Korea Sachio aims to provide collective health care solutions with focus on 3 therapeutic segments. Gastro care, Ortho care and Immunity management.
Sachio offers World class innovative products to keep patients active & healthy.
Mission :
At Sachio, Health matters….In the quest to provide healthcare for all, their mission is to launch innovative products using novel technologies with assurance of high quality products and services at affordable prices that will help the ailing masses.
Vision :
To become the most valued Pharma Company for making a big difference in the quality of life of the people as at Sachio only Health matters.
CEO Details
Mr. Sandip Bhikaji Tawde
Graduate with an executive MBA from IIM Ahmedabad.
Mr. Sandip Bhikaji Tawde, Director – Sachio Pharma Bangalore Pvt. Ltd.
A passionate pharma professional with a rich experience of more than 3 decades in the industry. Moved up the ladder from the level of a medical representative based on the strength of brand building all throughout the career. He was heading sales as General Manager with Zydus Cadila, cluster head at Torrent heading 2 divisions, Vice President at Alembic and Zuventus, heading multiple divisions. He is one who believes in science and one among the few who very early in career understood the importance of relation building and built brands like Ceftum during his representative days, was heading sales when Pantocid became a 50 crore brand and continued with a career pathway which is etched with success stories of building brands like Nucoxia MR, two 100 crore brands Aten and Nexpro and Shelcal a 200 crore plus brand. If these brands to be considered having a legacy on which he built made them bigger then Zosa and Progermina are 2 brands that he launched and made them both 10 crore brands in the very first year itself. He was awarded by AWACS for the second best launch of the year for Progermina in the year 2018.
By qualification he is a graduate with an executive MBA from IIM Ahmedabad, which he did during his Zydus days. During the period he was trained in Finance management, Supply chain management and Distribution management to name a few among the various others as part of the curriculum i handling pharma business. Sales & Marketing and Man management however has been his core strength which he has been exhibiting throughout his illustrious career. One of the most dependable pharma professionals who is counted upon by both internal and external customers alike.
A leader who always leads from the front by setting examples and motivating teams to perform. A passionate Brand Builder who believes in Building People to Build Business. A leader who believes in Shared vision with his team and drives them with a single point focus.
In June 2021, with the backing of his experience of 30 years in the pharma industry and moral and financial support from well-wishers among the doctor fraternity and associated industries, he transforms himself from a pharmaceutical professional to a pharmaceutical entrepreneur.
He takes over Sachio Pharma Bangalore Pvt. Ltd. is a pharma company launched in 2013 and was having its headquarters at Bangalore. Post take over, Sachio pharma operations are shifted to Mumbai , with its Headquarters at Office 113, E square, Subash Road, Vile Parle East. Field operations were expanded to 10 states across the country with a sanctioned field force of 91 in the first year. At HO also there are 13 employees making the total strength to be 104 plus.
